SCHEMBL16291869

SCHEMBL16291869

O=C(CNCc1cc(C(=O)O)ccn1)NCCCCCN(Cc1ccccc1)C1CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 11/20 0.50
▸ KDM5A P29375 6/20 0.43
▸ KDM5C P41229 6/20 0.43
▸ KDM4A O75164 3/20 0.43
▸ KDM4C Q9H3R0 2/20 0.43
▸ KDM6B O15054 1/20 0.43
▸ KDM2B Q8NHM5 1/20 0.43
▸ ACKR3 P25106 1/20 0.42
▸ KDM4B O94953 1/20 0.41
▸ DRD3 P35462 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ DRD2 P14416 1/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ MEP1B Q16820 1/20 0.35
▸ APP P05067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15636990 0.85 KDM5B (0.60) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL18708309 0.85 KDM5B (0.57) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL19574653 0.83 KDM5B (0.70) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL16291866 0.78 KDM5B (0.44) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL16006904 0.76 ACKR3 (0.39) KDM5BKDM5CKDM4AKDM4CACKR3
SCHEMBL16291896 0.76 KDM5B (0.57) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL16291759 0.74 KDM5B (0.49) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL16293306 0.74 CHRM2 (0.55) ACKR3KDM4E
SCHEMBL15994092 0.73 KDM5B (0.42) KDM5BKDM5AKDM5CKDM4AKDM4C
SCHEMBL28168442 0.72 KDM5B (0.44) KDM5BACKR3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189787-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-01-29 — — US disclosed
US-9611219-B2 — — 2017-04-04 — — US disclosed
US-9611220-B2 — — 2017-04-04 — — US disclosed
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2015-07-23 — — US disclosed
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189787-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 KDM5B 34/4885KDM5A 24/4885KDM5C 31/4885
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 KDM5B 34/4885KDM5A 25/4885KDM5C 31/4885
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 KDM5B 34/4885KDM5A 24/4885KDM5C 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback